Nanoparticle albumin‐bound paclitaxel in elder patients with advanced squamous non‐small‐cell lung cancer: A retrospective study
Abstract Purpose This study aimed to assess the effect of nanoparticle albumin‐bound paclitaxel (nab‐PTX) chemotherapy regimens in elderly patients (≥70 years old) with advanced squamous non‐small‐cell lung cancer (NSCLC). Patients and Methods The clinical records of elderly patients aged ≥70 years...
Main Authors: | Yang Liu, Yinping Dong, Hui Zhu, Wang Jing, Hongbo Guo, Jinming Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-02-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2791 |
Similar Items
-
Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC)
by: Qi Song, et al.
Published: (2021-09-01) -
Albumin-bound paclitaxel in the treatment of metastatic breast cancer
by: E V Artamonova
Published: (2017-01-01) -
Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
by: Yafan Yang, et al.
Published: (2023-03-01) -
Metformin Suppresses Stemness of Non-Small-Cell Lung Cancer Induced by Paclitaxel through FOXO3a
by: Zhimin Tang, et al.
Published: (2023-11-01) -
Low‐dose gemcitabine plus nab‐paclitaxel versus standard‐dose gemcitabine plus nab‐paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase II trial
by: Ken Kamata, et al.
Published: (2023-09-01)